Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 9 hrs 3 mins

S&P Futures
4,533.50
+25.00(+0.55%)
Dow Futures
34,199.00
+197.00(+0.58%)
Nasdaq Futures
15,940.75
+71.00(+0.45%)
Russell 2000 Futures
2,165.10
+18.80(+0.88%)
Crude Oil
65.94
+0.37(+0.56%)
Gold
1,777.80
-6.50(-0.36%)

Advertisement

Accelerate Diagnostics, Inc. (AXDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

4.9400

-0.0600

(-1.20%)

At close: 04:00PM EST

5.0000

+0.06

(+1.21%)

After hours:

06:11PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	5.0000
Open	5.2100
Bid	4.9600 x 1100
Ask	4.9300 x 1100
Day's Range	4.8600 - 5.2100
52 Week Range	4.7800 - 15.6000
Volume	631,080
Avg. Volume	392,808

Market Cap	301.557M
Beta (5Y Monthly)	1.88
PE Ratio (TTM)	N/A
EPS (TTM)	-1.4250
Earnings Date	Aug 04, 2021 - Aug 09, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	13.00

All

News

Press Releases

Research Reports

Simply Wall St.
The Independent Director of Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Jack Schuler, Just Bought 5.8% More Shares
Accelerate Diagnostics, Inc. ( NASDAQ:AXDX ) shareholders (or potential shareholders) will be happy to see that the...
- Insider Buying: The BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Senior VP & CFO Just Bought 60% More Shares
  Simply Wall St.
- The President of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), Christopher Peetz, Just Bought 3.3% More Shares
  Simply Wall St.
Simply Wall St.
Accelerate Diagnostics (NASDAQ:AXDX) investors are sitting on a loss of 78% if they invested five years ago
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...
- Investors in NWF Group (LON:NWF) have made a notable return of 39% over the past three years
  Simply Wall St.
- The past year for Root (NASDAQ:ROOT) investors has not been profitable
  Simply Wall St.
PR Newswire
New Accelerate Pheno® System Multi-Center Study Published in Clinical Infectious Diseases
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the publication of its Improving Outcomes and Antibiotic Stewardship (IOAS) Study in the journal Clinical Infectious Diseases. The multi-center, real-world study compared data before and after implementation of the Accelerate Pheno system across several hospitals to determine its impact on the treatment of patients with bloodstream infections. The data showed statistically significant reductions in time to optimal antimicrobial therapy,

Advertisement

S&P Futures4,533.50+25.00(+0.55%)

Dow Futures34,199.00+197.00(+0.58%)

Nasdaq Futures15,940.75+71.00(+0.45%)

Russell 2000 Futures2,165.10+18.80(+0.88%)

Crude Oil65.94+0.37(+0.56%)

Gold1,777.80-6.50(-0.36%)

Accelerate Diagnostics, Inc. (AXDX)

Chart Events

Performance Outlook

The Independent Director of Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Jack Schuler, Just Bought 5.8% More Shares

Accelerate Diagnostics (NASDAQ:AXDX) investors are sitting on a loss of 78% if they invested five years ago

New Accelerate Pheno® System Multi-Center Study Published in Clinical Infectious Diseases

S&P Futures
4,533.50
+25.00(+0.55%)

Dow Futures
34,199.00
+197.00(+0.58%)

Nasdaq Futures
15,940.75
+71.00(+0.45%)

Russell 2000 Futures
2,165.10
+18.80(+0.88%)

Crude Oil
65.94
+0.37(+0.56%)

Gold
1,777.80
-6.50(-0.36%)